申请人:BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASK
公开号:US20190322680A1
公开(公告)日:2019-10-24
Provided herein are compounds and methods for modulating the NFKB pathway. More particularly, provided are inhibitors of the NFKB pathway and the uses of such inhibitors in regulating diseases and disorders, e.g., to treat cancer, autoimmune diseases, inflammatory diseases, diabetes, cardiovascular diseases, or neurological diseases.